Form 8-K - Current report:
SEC Accession No. 0001104659-18-006007
Filing Date
2018-02-02
Accepted
2018-02-02 07:04:22
Documents
4
Period of Report
2018-02-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-5152_18k.htm 8-K 28115
2 EX-99.1 a18-5152_1ex99d1.htm EX-99.1 901167
3 EX-99.2 a18-5152_1ex99d2.htm EX-99.2 1176709
4 GRAPHIC g51521mm01i001.jpg GRAPHIC 3923
  Complete submission text file 0001104659-18-006007.txt   2112831
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 18568602
SIC: 2834 Pharmaceutical Preparations